A detailed history of Federation Des Caisses Desjardins Du Quebec transactions in Glaukos Corp stock. As of the latest transaction made, Federation Des Caisses Desjardins Du Quebec holds 235 shares of GKOS stock, worth $35,536. This represents 0.0% of its overall portfolio holdings.

Number of Shares
235
Previous 310 24.19%
Holding current value
$35,536
Previous $36,000 16.67%
% of portfolio
0.0%
Previous 0.0%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$113.62 - $135.39 $8,521 - $10,154
-75 Reduced 24.19%
235 $30,000
Q2 2024

Aug 14, 2024

BUY
$89.48 - $118.35 $894 - $1,183
10 Added 3.33%
310 $36,000
Q1 2024

May 15, 2024

BUY
$76.4 - $96.33 $22,920 - $28,899
300 New
300 $28.3 Million
Q4 2022

Aug 14, 2024

SELL
$40.82 - $57.75 $6,123 - $8,662
-150 Reduced 33.33%
300 $13.1 Million
Q2 2022

Aug 14, 2024

SELL
$34.86 - $63.77 $6,972 - $12,754
-200 Reduced 30.77%
450 $20.4 Million
Q1 2022

Aug 14, 2024

BUY
$44.33 - $57.82 $15,072 - $19,658
340 Added 109.68%
650 $37.6 Million
Q3 2021

Aug 30, 2024

BUY
$47.43 - $84.23 $4,743 - $8,423
100 Added 18.18%
650 $31.3 Million
Q2 2021

Aug 30, 2024

BUY
$73.06 - $97.7 $17,534 - $23,448
240 Added 77.42%
550 $46.7 Million
Q1 2021

Aug 30, 2024

SELL
$70.43 - $97.42 $8,803 - $12,177
-125 Reduced 21.74%
450 $37.8 Million
Q4 2020

Aug 30, 2024

SELL
$48.9 - $75.26 $35,452 - $54,563
-725 Reduced 55.77%
575 $43.3 Million
Q2 2020

Aug 30, 2024

SELL
$28.78 - $46.83 $8,634 - $14,049
-300 Reduced 18.75%
1,300 $49.9 Million
Q4 2018

Aug 30, 2024

BUY
$52.18 - $67.93 $67,312 - $87,629
1,290 Added 416.13%
1,600 $89.9 Million
Q3 2018

Aug 30, 2024

SELL
$38.13 - $68.37 $3,813 - $6,837
-100 Reduced 5.88%
1,600 $104 Million
Q2 2018

Aug 30, 2024

BUY
$27.62 - $44.51 $46,954 - $75,667
1,700 New
1,700 $69.1 Million
Q2 2017

Aug 30, 2024

SELL
N/A
-300 Closed
0 $0
Q1 2017

Aug 30, 2024

SELL
N/A
-10
300 $15.4 Million

Others Institutions Holding GKOS

About GLAUKOS Corp


  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $7.2B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Federation Des Caisses Desjardins Du Quebec Portfolio

Follow Federation Des Caisses Desjardins Du Quebec and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Federation Des Caisses Desjardins Du Quebec, based on Form 13F filings with the SEC.

News

Stay updated on Federation Des Caisses Desjardins Du Quebec with notifications on news.